deltatrials

Alzheimer's disease Trials in Portland, United States

Conditions / Alzheimer's disease / Portland, United States

Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.

55 total trials for this combination

Showing top 10 of 55 trials

Trials

NCT ID Title Status Phase
NCT00676143 Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients TERMINATED PHASE3
NCT04004767 TRC-PAD Program: In-Clinic Trial-Ready Cohort COMPLETED
NCT00667810 Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients TERMINATED PHASE3
NCT04374253 A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) TERMINATED PHASE3
NCT04437511 A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) ACTIVE_NOT_RECRUITING PHASE3
NCT05637801 A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) ACTIVE_NOT_RECRUITING NA
NCT05617014 Alzheimer's Disease Neuroimaging Initiative 4 ENROLLING_BY_INVITATION
NCT04520412 A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease SUSPENDED PHASE3
NCT00105547 Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's COMPLETED PHASE3
NCT05929703 Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders RECRUITING NA

Related Pages